Skip to main content

Table 3 CSF Analysis on Biweekly 40 mg IT Trastuzumab (Total 80 mg Weekly)

From: Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

Week

1

2

3

4

Protein (g/L)

34

28

33

26

30

31

61a

RBC (/cmm3)

<1

1

<1

1

<1

1

1

WBC (/cmm3)

<1

<1

<1

1

2

1

<1

  1. CSF samples were obtained prior to IT Trastuzumab injection
  2. IT intrathecal, CSF cerebrospinal fluid, RBC red blood cell, WBC white blood cell
  3. aindicates high CSF protein
Back to article page